Achelios Therapeutics
John Fort has held various high-level positions in the medical field throughout their career. John currently serves as the Chief Medical Officer at Achelios Therapeutics, VPD Partners, and Aralez Pharmaceuticals Inc. Prior to this, John held positions such as Chief Scientific Advisor at Aralez Pharmaceuticals Inc. and Chief Medical Officer at Pozen, Inc. John also has experience as VP of Medical Affairs at Adolor, VP of Global Medical Affairs at Pharmacia/Pfizer, and VP of Global Medical Affairs at G.D. Searle. Additionally, John served as an Associate Professor of Medicine at Thomas Jefferson University.
Achelios Therapeutics
Achelios Therapeutics’ lead reformulation product, TOPOFEN™, pairs its proprietary ACHETOGEL™ delivery technology with the proven NSAID ketoprofen. In pre-clinical and early-stage clinical studies, they have shown TOPOFEN™ (ketoprofen) to provide superior tissue penetration compared to other topical formulations currently on the market.